EPIPHANY TECHNOLOGY ACQ-CL A (EPHY) Earnings History & Surprises

NASDAQ:EPHYUS29429X1090

Current stock price

10.095 USD
0 (-0.05%)
At close:
10.0901 USD
0 (-0.05%)
After Hours:

EPHY Earnings overview

Past quarterly earnings results for EPIPHANY TECHNOLOGY ACQ-CL A (EPHY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A

Last Reported

Most Recent
Release Date
N/A
Period
Q3 / 2022
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2022 - - - -
Q2 2022 - - - -
Q1 2022 - - - -
Q4 2021 - - - -
Q3 2021 - - - -
Q2 2021 - - - -
Q1 2021 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

EPIPHANY TECHNOLOGY ACQ-CL A / EPHY Earnings FAQ

Can you provide information on whether EPIPHANY TECHNOLOGY ACQ-CL A beat earnings estimates in the last quarter?

EPIPHANY TECHNOLOGY ACQ-CL A (EPHY) missed EPS estimates and missed revenue estimates in the most recent quarter.